tag:blogger.com,1999:blog-4241416962008169508.post4299083065330470848..comments2024-03-27T21:03:58.972-04:00Comments on Just A Life Sciences Blog...: With A New Class Of Lipid-Levels Management Biologics Arriving -- Will Merck's Zetia® Soon Lose Her Voice?Unknownnoreply@blogger.comBlogger2125tag:blogger.com,1999:blog-4241416962008169508.post-25820705939709672222013-10-17T06:35:06.769-04:002013-10-17T06:35:06.769-04:00Thank you so much, Anon.!
It didn't occur to ...Thank you so much, Anon.!<br /><br />It didn't occur to me to run down the backgrounds on Regeneron's management and board, when I grabbed their logo from Google Images.<br /><br />As you can readily see, I've highlighted your keen insight into the previously-unnoticed irony here, as an update to the story.<br /><br />Do stop back!<br /><br />Namaste<br />Condorhttp://shearlingsplowed.blogspot.comnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-84923195642959769122013-10-16T20:32:40.781-04:002013-10-16T20:32:40.781-04:00Small circle & arrow to insert here, Condor. R...Small circle & arrow to insert here, Condor. Regeneron, the partner development company here, is home to none other that P. Roy Vagelos. Dr. Vagelos was the last scientific CEO of Merck. Isn't it ironic?Anonymousnoreply@blogger.com